0.0124	1.0583	OMIM:231090	HYDATIDIFORM MOLE	NLRP7	199713
0.0124	1.0583	OMIM:305690	GENITOURINARY TRACT ANOMALIES		
0.0124	1.0583	OMIM:600171	GONADAL AGENESIS		
0.0124	1.0583	OMIM:191600	URETER, CANCER OF		
0.0124	1.0583	OMIM:149600	LABIA MINORA, INCOMPLETE ADHESION OF		
0.0124	1.0583	OMIM:191800	URINARY BLADDER, ATONY OF		
0.0213	2.0542	OMIM:273250	TESTICULAR REGRESSION SYNDROME		
0.0279	1.9856	OMIM:264300	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	HSD17B3	3293
0.0331	2.4541	ORPHANET:242	46,XY COMPLETE GONADAL DYSGENESIS	MAP3K1, SRY, CBX2, DMRT1, NR0B1, DHH, DMRT2, NR5A1	4214, 6736, 84733, 1761, 190, 50846, 10655, 2516
0.1043	2.5355	OMIM:136680	FRASIER SYNDROME	WT1	7490
0.1083	2.6350	OMIM:201810	#201810 3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF;;3-@BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY;;3-@BETA-HSD DEFICIENCY; HSDB;;ADRENAL HYPERPLASIA II	HSD3B2	3284
0.1261	2.2872	OMIM:261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	AMH, AMHR2	268, 269
0.1261	2.0683	OMIM:400044	#400044 46,XY SEX REVERSAL 1; SRXY1;;46,XY SEX REVERSAL, SRY-RELATED;;46,XY GONADAL DYSGENESIS, COMPLETE, SRY-RELATED46,XY TRUE HERMAPHRODITISM, SRY-RELATED, INCLUDED;;TESTIS-DETERMINING FACTOR, X-CHROMOSOMAL, FORMERLY, INCLUDED; TDFX,FORMERLY, INCLUDED;;SEX-REVERSING LOCUS ON X, FORMERLY, INCLUDED; SRVX, FORMERLY, INCLUDED	SRY	6736
0.1330	1.9423	ORPHANET:2666	ADULT FAMILIAL NEPHRONOPHTISIS - SPASTIC QUADRIPARESIA		
0.1350	1.4902	DECIPHER:14	PRADER-WILLI SYNDROME (TYPE 1)		
0.1350	1.4902	DECIPHER:53	PRADER-WILLI SYNDROME (TYPE 2)		
0.1402	2.2025	OMIM:604387	#604387 NEPHRONOPHTHISIS 3; NPHP3;;NPH3	NPHP3	27031
0.1407	2.0886	OMIM:152780	LUTEINIZING HORMONE, BETA POLYPEPTIDE	LHB	3972
0.1451	1.6765	OMIM:222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	SI	6476
0.1738	1.9446	OMIM:264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS	SRD5A2	6716
